Himadri Speciality Chemical (HSCL.BO) Earnings Analysis
Himadri Speciality Chemical (HSCL.BO) next reports earnings on 2026-10-15. Last quarter (2026-07-15) it beat with EPS 4.6 INR vs 4.4 INR est (+4.5%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E 51.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does HSCL.BO next report earnings?
| Next earnings date | 2026-10-15 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
HSCL.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-15 | 4.6 INR | 4.4 INR | +4.5% | Beat |
| 2026-04-23 | 4.05 INR | 4.1 INR | -1.2% | Miss |
| 2026-01-16 | 3.85 INR | 3.9 INR | -1.3% | Miss |
| 2025-10-14 | 3.55 INR | 3.8 INR | -6.6% | Miss |
| 2025-07-14 | 3.65 INR | 3.2 INR | +14.1% | Beat |
| 2025-04-21 | 3.2 INR | 3.1 INR | +3.2% | Beat |
| 2025-01-13 | 2.9 INR | 2.7 INR | +7.4% | Beat |
| 2024-10-16 | 2.72 INR | n/a | n/a | n/a |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
HSCL.BO valuation and analyst view
| Trailing P/E | 51.58 |
|---|---|
| Trailing EPS | 14.893 INR |
| Price / book | 8.33 |
| Dividend yield | 0.10% |
| Market cap | 386.46B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Himadri Speciality Chemical (HSCL.BO)'s next earnings date?
Himadri Speciality Chemical is next scheduled to report on 2026-10-15.
Did HSCL.BO beat earnings last quarter?
In its 2026-07-15 report, HSCL.BO posted EPS of 4.6 INR versus a 4.4 INR estimate — a beat of 4.5%.
What is HSCL.BO's earnings track record?
Over the last 7 reported quarters with consensus data, HSCL.BO beat estimates 4 times (57%).
What is HSCL.BO's current P/E ratio and EPS?
HSCL.BO trades at a trailing P/E of 51.58 on trailing EPS of 14.892853674055544 INR.
What do analysts rate HSCL.BO?
HSCL.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.